Novo Nordisk shares pop 10% on early-stage weight loss drug trial results

A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024.

Tom Little | Reuters

Shares of Novo Nordisk jumped Friday after the Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

The trial showed average weight reduction of 22% in obese and overweight patients after 36 weeks.

Shares were last up 9.5% at 11:02 a.m. London time.

This is a developing story. Please check back for updates.

Source

World

European companies are jumping on the defense bandwagon as EU plans security splurge

July 17, 2025

From cruise ships to telecommunications, European companies are finding ways to increasingly pivot to military contracts as they seek to cash in on a defense boom that’s sweeping the continent. Europe’s defense sector has exploded in value this year, with the industry’s publicly listed companies riding a wave of bullish sentiment that has seen some […]

World

New U.S. assessment finds American strikes destroyed only one of three Iranian nuclear sites

July 17, 2025

A satellite view shows an overview of Fordow underground complex, after the U.S. struck the underground nuclear facility, near Qom, Iran June 22, 2025. Maxar Technologies | Via Reuters WASHINGTON — One of the three nuclear enrichment sites in Iran struck by the United States last month was mostly destroyed, setting work there back significantly. […]

World

Sweden’s Volvo Cars pops 10% on quarterly profit beat

July 17, 2025

Volvo vehicles seen outside a Volvo dealership in Edmonton, AB, Canada, on February 02, 2025. Nurphoto | Nurphoto | Getty Images Shares of Sweden-based automaker Volvo Cars rose more than 10% on Thursday as the company’s second-quarter operating profit beat analyst expectations despite a sharp year-on-year decline. Volvo Cars, which is owned by China’s Geely […]